Neuropharmacology of SQ 10,996, a compound with several therapeutic indications.
D000577:Amides / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D001007:Anxiety; D001522:Behavior, Animal / Q000187:drug effects; D002220:Carbamazepine / Q000494:pharmacology; D002415:Cats; D003655:Decerebrate State; D003989:Dibenzoxazepines / Q000494:pharmacology*; D004558:Electric Stimulation; D004597:Electroshock; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D051379:Mice; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000517:prevention & control; D014276:Trigeminal Nerve / Q000187:drug effects
D000577:Amides; D000927:Anticonvulsants; D000928:Antidepressive Agents; D003989:Dibenzoxazepines; C002988:SQ 10996; D002220:Carbamazepine; D010672:Phenytoin; D010433:Pentylenetetrazole